Cadila Pharma introduces vaccine for seasonal flu
The new vaccine targets four strains of the influenza virus subtype -A and B, responsible for seasonal epidemics, the drug firm said in a statement. Developed using proprietary technology employing nano-sized particles, the vaccine mimics the external structure of the virus without containing intact genetic material, it added.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Epidemics | Epidemiology | Genetics | Influenza | Influenza Vaccine | Nanotechnology | Pharmaceuticals | Vaccines